Form 4 for BDX Becton Dickinson
Accepted 2025-07-22 00:00:00 ET · period of report 2025-07-18 · accession 0001062993-25-013065 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-22 | 2025-07-18 | BDX | Garrison Michael David | EVP, Pres, Medical | M - OptEx | $147.68 | +6,360 | 11.2K | +130% | +$939.2K |
| D | 2025-07-22 | 2025-07-18 | BDX | Garrison Michael David | EVP, Pres, Medical | D - Sale to Iss | $180.29 | -5,175 | 6,072 | -46% | -$933.0K |
| DM | 2025-07-22 | 2025-07-18 | BDX | Garrison Michael David | EVP, Pres, Medical | S - Sale+OE | $180.29 | -1,185 | 4,887 | -20% | -$213.6K |
| D | 2025-07-22 | 2025-07-18 | BDX | Garrison Michael David | EVP, Pres, Medical | M - OptEx | $0.00 | -6,360 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-18 | M | A | 6,360 | $147.68 | 11,247 | D | — | — | |
| 2 | Common | Common Stock | 2025-07-18 | D | D | 5,175 | $180.29 | 6,072 | D | — | — | |
| 3 | Common | Common Stock | 2025-07-18 | S | D | 1,184 | $180.29 | 4,888 | D | — | — | |
| 4 | Common | Common Stock | 2025-07-18 | S | D | 1 | $181.50 | 4,887 | D | — | — | |
| 5 | Derivative | Stock Appreciation Rights | 2025-07-18 | M | D | 6,360 | $0.00 | 0 | D | $147.68 · 2016-11-26 to 2025-11-26 | 6,360 Common Stock | (F1) The stock appreciation rights vested in four annual installments beginning one year after grant. |